GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Greenrose Holding Co (OTCPK:GNRS) » Definitions » Sloan Ratio %

The Greenrose Holding Co (The Greenrose Holding Co) Sloan Ratio % : 0.00% (As of Sep. 2022)


View and export this data going back to 2020. Start your Free Trial

What is The Greenrose Holding Co Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

The Greenrose Holding Co's Sloan Ratio for the quarter that ended in Sep. 2022 was 0.00%.

As of Sep. 2022, The Greenrose Holding Co has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


The Greenrose Holding Co Sloan Ratio % Historical Data

The historical data trend for The Greenrose Holding Co's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Greenrose Holding Co Sloan Ratio % Chart

The Greenrose Holding Co Annual Data
Trend Dec19 Dec20 Dec21
Sloan Ratio %
- -4.31 -

The Greenrose Holding Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of The Greenrose Holding Co's Sloan Ratio %

For the Drug Manufacturers - Specialty & Generic subindustry, The Greenrose Holding Co's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Greenrose Holding Co's Sloan Ratio % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Greenrose Holding Co's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where The Greenrose Holding Co's Sloan Ratio % falls into.



The Greenrose Holding Co Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

The Greenrose Holding Co's Sloan Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2021 )-Cash Flow from Operations (A: Dec. 2021 )
-Cash Flow from Investing (A: Dec. 2021 ))/Total Assets (A: Dec. 2021 )
=(0-0
-0)/239.093
=0.00%

The Greenrose Holding Co's Sloan Ratio for the quarter that ended in Sep. 2022 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Sep. 2022 )
=(-60.939--5.786
--1.085)/175.766
=-30.76%

The Greenrose Holding Co's Net Income for the trailing twelve months (TTM) ended in Sep. 2022 was 0 (Dec. 2021 ) + -14.568 (Mar. 2022 ) + -10.336 (Jun. 2022 ) + -36.035 (Sep. 2022 ) = $-60.94 Mil.
The Greenrose Holding Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2022 was 0 (Dec. 2021 ) + -3.662 (Mar. 2022 ) + 2.474 (Jun. 2022 ) + -4.598 (Sep. 2022 ) = $-5.79 Mil.
The Greenrose Holding Co's Cash Flow from Investing for the trailing twelve months (TTM) ended in Sep. 2022 was 0 (Dec. 2021 ) + -0.419 (Mar. 2022 ) + -0.868 (Jun. 2022 ) + 0.202 (Sep. 2022 ) = $-1.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Greenrose Holding Co  (OTCPK:GNRS) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Sep. 2022, The Greenrose Holding Co has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


The Greenrose Holding Co Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of The Greenrose Holding Co's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


The Greenrose Holding Co (The Greenrose Holding Co) Business Description

Traded in Other Exchanges
Address
111 Broadway, Amityville, NY, USA, 11701
The Greenrose Holding Co is engaged in the manufacture and processing of cannabis in the adult-use and medical cannabis marketplace in Connecticut and Arizona.
Executives
Bernard Wang officer: CHIEF FINANCIAL OFFICER 5575 TERRACE DR., LA CRESCENTA CA 91214
Benjamin Rose director 10115 JEFFERSON BOULEVARD, CULVER CITY CA 90232
True Harvest, Llc 10 percent owner 4216 N. 43RD STREET, PHOENIX AZ 85018
Michael Macchiaroli 10 percent owner 4216 N. 43RD STREET, PHOENIX AZ 85018
Scott Jeffrey Cohen officer: Chief Financial Officer C/O GREENROSE ASSOCIATES LLC, 111 BROADWAY, AMITYVILLE NY 11701
Greenrose Associates Llc 10 percent owner 1000 WESTBURY AVENUE, WESTBURY NY 11590
Steven Francis Cummings director, 10 percent owner 1000 WOODBURY ROAD, SUITE 212, WOODBURY NY 11797
Daniel Patrick Harley director, 10 percent owner, officer: Executive Vice-President 1000 WOODBURY ROAD, SUITE 212, WOODBURY NY 11797
John Iii Torrance director, 10 percent owner 1000 WOODBURY ROAD, WOODBURY NY 11797
Thomas J Megale director 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
John Falcon director, 10 percent owner 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
Jeffrey Stegner 10 percent owner, officer: Chief Financial Officer 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
Brendan Sheehan director, 10 percent owner, officer: Executive Vice-President 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
William Iii Harley director, 10 percent owner, officer: Chief Executive Officer 1000 WOODBURY ROAD, WOODBURY NY 11797
Paul Otto Wimer 10 percent owner, officer: President 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797